Aktaş Y - Search Results

1

In Vitro Cellular Uptake and Insulin Secretion Studies on INS-1E Cells of Exendin-4 Loaded Self Nanoemulsifying Drug Delivery Systems.

Çelik Tekeli M, Yalçin Y, Verdi H, Aktaş Y, Çelebi N. Çelik Tekeli M, et al. Among authors: aktas y. Pharm Dev Technol. 2024 Oct 30:1-17. doi: 10.1080/10837450.2024.2423823. Online ahead of print. Pharm Dev Technol. 2024. PMID: 39474799

2

Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line.

Aktas Y, Celik Tekeli M, Celebi N. Aktas Y, et al. J Microencapsul. 2020 Jan;37(1):41-51. doi: 10.1080/02652048.2019.1692945. J Microencapsul. 2020. PMID: 31714163

3

Evaluation of the hypoglycemic effect of exendin-4's new oral self-nanoemulsifying system in rats.

Celik-Tekeli M, Celebi N, Tekeli MY, Aktas Y. Celik-Tekeli M, et al. Among authors: aktas y. Eur J Pharm Sci. 2021 Mar 1;158:105644. doi: 10.1016/j.ejps.2020.105644. Epub 2020 Nov 13. Eur J Pharm Sci. 2021. PMID: 33197556

4

Development and Characterization of Insulin-loaded Liposome-chitosan-Nanoparticle (LCS-NP) Complex and Investigation of Transport Properties Through a Pancreatic Beta Tc Cell Line.

Çelik Tekeli M, Yücel Ç, Ünal S, Aktaş Y. Çelik Tekeli M, et al. Among authors: aktas y. Turk J Pharm Sci. 2018 Apr;15(1):91-96. doi: 10.4274/tjps.70783. Epub 2018 Apr 2. Turk J Pharm Sci. 2018. PMID: 32454645 Free PMC article.

5

Oral self-nanoemulsifying formulation of GLP-1 agonist peptide exendin-4: development, characterization and permeability assesment on Caco-2 cell monolayer.

Tekeli MC, Aktas Y, Celebi N. Tekeli MC, et al. Among authors: aktas y. Amino Acids. 2021 Jan;53(1):73-88. doi: 10.1007/s00726-020-02926-0. Epub 2021 Jan 4. Amino Acids. 2021. PMID: 33398527

6

May Biodegradable and Biocompatible Polymeric Microneedles be Considered as a Vaccine and Drug Delivery System in the COVID-19 Pandemic?

Ünal S, Doğan O, Aktaş Y. Ünal S, et al. Among authors: aktas y. Turk J Pharm Sci. 2021 Oct 28;18(5):527-529. doi: 10.4274/tjps.galenos.2021.52323. Turk J Pharm Sci. 2021. PMID: 34707165 Free PMC article. No abstract available.

7

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.

Ünal S, Doğan O, Aktaş Y. Ünal S, et al. Among authors: aktas y. Beilstein J Nanotechnol. 2022 Nov 23;13:1393-1407. doi: 10.3762/bjnano.13.115. eCollection 2022. Beilstein J Nanotechnol. 2022. PMID: 36483636 Free PMC article.

8

Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors.

Ünal S, Varan G, Benito JM, Aktaş Y, Bilensoy E. Ünal S, et al. Among authors: aktas y. Beilstein J Org Chem. 2023 Feb 13;19:139-157. doi: 10.3762/bjoc.19.14. eCollection 2023. Beilstein J Org Chem. 2023. PMID: 36814451 Free PMC article.

9

Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus.

Yücel Ç, Karatoprak GŞ, Aktaş Y. Yücel Ç, et al. Among authors: aktas y. J Nanosci Nanotechnol. 2018 Jun 1;18(6):3856-3864. doi: 10.1166/jnn.2018.15247. J Nanosci Nanotechnol. 2018. PMID: 29442719

10

Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.

Ünal S, Aktaş Y, Benito JM, Bilensoy E. Ünal S, et al. Among authors: aktas y. Int J Pharm. 2020 Jun 30;584:119468. doi: 10.1016/j.ijpharm.2020.119468. Epub 2020 May 26. Int J Pharm. 2020. PMID: 32470483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters